Clinical Trials Logo

Vitreoretinal Disease clinical trials

View clinical trials related to Vitreoretinal Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT06429969 Recruiting - Clinical trials for Vitreoretinal Disease

Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

NMR
Start date: January 17, 2024
Phase:
Study type: Observational

The goal of this observational study was to learn about metabolomics profiles in vitreoretinal diseases by nuclear magnetic resonance (NMR)using vitreous fluid. The main question it aimed to answer was abnormal biomarkers for common retinal diseases such as idiopathic macular hole(IMH), diabetic retinopathy(DR) and retinal detachment(RD). Participants would not be subjected to any intervention and the investigators would only collect preoperative information and remaining vitreous samples. The investigators divided the participants into groups with appropriate disease names based on the disease diagnosis, such as IMH group, DR group, and RD group. The MH group was used as a control group, investigators compared other groups to see the metabolomic abnormalities.

NCT ID: NCT06294613 Recruiting - Clinical trials for Vitreoretinal Disease

A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases

Start date: February 8, 2024
Phase: N/A
Study type: Interventional

Prospective, interventional, open-label, non-controlled, monocentric study in Belgium of Luca, of up to 7 evaluable subjects, undergoing vitreoretinal surgery to treat intravitreal hemorrhage and macular pucker. Only one eye per subject can be enrolled.

NCT ID: NCT06123923 Completed - Clinical trials for Vitreoretinal Disease

Trends of Vitreoretinal Surgery in Children

Start date: October 16, 2022
Phase:
Study type: Observational

Purpose: We determined the incidence, etiology, and longitudinal trends of vitreoretinal diseases necessitating pars plana vitrectomy (PPV) in the pediatric and adolescent population. Design: This was a nationwide, population-based cohort study, utilizing data from the Korean National Health Claims database spanning from 2009 to 2020. Given the retrospective design of the study and the anonymized nature of the data, the requirement for informed consent was waived. Methods: All pediatric and adolescent patients (under 20 years of age) who underwent PPV across the Korean population were included. The cumulative incidence of PPV was estimated from 2009 to 2020, with 2009 to 2011 as the washout period. The annual trends of PPV incidence, the proportion of each etiology, and comorbidity were estimated based on sex and specific age groups.

NCT ID: NCT04257188 Completed - Clinical trials for Vitreoretinal Diseases

Safety and Feasibility of Sutureless Pars-plana Vitrectomy in Sub-Tenon Anesthesia

SAFE-VISA
Start date: November 7, 2019
Phase:
Study type: Observational

The aim of this prospective study is to investigate the feasibility of performing minimally invasive vitrectomy under sub-tenon anesthesia in terms of intraoperative patients' tolerance and the surgeon's confidence. In particular, the tolerance and pain sensation during the operation as well as the possible perception of light and colour sensations are to be recorded with the help of questionnaires. In addition, the surgeon's impressions regarding eye motility, chemosis and general feasibility will be evaluated.

NCT ID: NCT02477605 Completed - Clinical trials for Vitreoretinal Disease

Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes

Start date: July 16, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the treatment day change between immediate postoperative and immediate preoperative intraocular pressure (IOP) between 27-gauge and 23-gauge vitrectomy instruments.

NCT ID: NCT00744666 Recruiting - Ocular Hypertension Clinical Trials

IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids

IVTA:PRE-TREAT
Start date: September 2008
Phase: Phase 4
Study type: Interventional

Intravitreal triamcinolone acetonide (IVTA) is a commonly employed treatment for various vitreoretinal disorders. However, approximately 23% to 50% of patients who receive IVTA develop ocular hypertension after the drug is injected into the eye. Similar to IVTA, topically administered corticosteroids eye drops result in ocular hypertension in approximately 33% of the population. It is unknown whether identifying patients who develop ocular hypertension from topical corticosteroids could be used to identify patients who are at risk for injectable IVTA. Therefore, the purpose of this study is to evaluate the efficacy of topical prednisolone 1% four times daily for one month as a screening test to reduce the incidence and severity of ocular hypertension after IVTA injection.